Mallinckrodt hit with kickback suit same day as settlement by Kyle Blankenship Wednesday, June 5, 2019 Chafing under federal kickback charges tied to its H.P. Acthar Gel, Mallinckrodt appeared to be clear with a settlement in the works. Not so fast.
DOJ joins the fray in Mallinckrodt's Acthar whistleblower suits by Kyle Blankenship Wednesday, May 1, 2019 Bad news for Mallinckrodt: Federal prosecutors will join plaintiffs in whistleblower suits alleging illegal marketing of Questcor's H.P. Acthar Gel.
Mallinckrodt hit back at Acthar whistleblower, lawsuit claims by Eric Sagonowsky Friday, April 13, 2018 Mallinckrodt is under more scrutiny this week with a whistleblower lawsuit alleging fraud, retaliation and more.
Mallinckrodt foiled Acthar rival to hike prices 85,000%: lawsuit by Eric Sagonowsky Tuesday, October 31, 2017 A set of Medicare payers accuse embattled Mallinckrodt of violating antitrust law to stifle competition for its $1 billion-plus Acthar Gel.
JAMA piece resurrects questions over cost of Mallinckrodt's Acthar by Eric Palmer Wednesday, September 13, 2017 A new study in JAMA has put the focus back on the price of Mallinckrodt's controversial med, H.P. Acthar gel.
